2: PN: US20040072744 SEQID: 2 claimed protein
Need Assistance?
  • US & Canada:
    +
  • UK: +

2: PN: US20040072744 SEQID: 2 claimed protein

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

A synthetic peptide with potential for the treatment of Down's syndrome and schizophrenia.

Category
Peptide APIs
Catalog number
BAT-010417
CAS number
389572-87-6
Molecular Formula
C43H67N13O17S
Molecular Weight
1070.13
2: PN: US20040072744 SEQID: 2 claimed protein
IUPAC Name
(4S)-5-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2R)-1-[[(2S)-3-carboxy-1-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-1-oxopropan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-[[2-[[(2S)-2-[[(2S)-2,4-diamino-4-oxobutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-5-oxopentanoic acid
Synonyms
PN; H-Asn-Leu-Gly-Glu-His-Pro-Val-Cys-Asp-Ser-OH; L-asparagyl-L-leucyl-glycyl-L-alpha-glutamyl-L-histidyl-L-prolyl-L-valyl-L-cysteinyl-L-alpha-aspartyl-L-serine
Appearance
Powder
Purity
≥95%
Density
1.414±0.06 g/cm3
Boiling Point
1660.8±65.0 °C at 760 Torr
Sequence
NLGEHPVCDS
Storage
Store at -20°C
Solubility
Soluble in Water
InChI
InChI=1S/C43H67N13O17S/c1-19(2)10-24(50-35(64)22(44)12-30(45)58)36(65)47-15-31(59)49-23(7-8-32(60)61)37(66)52-26(11-21-14-46-18-48-21)42(71)56-9-5-6-29(56)40(69)55-34(20(3)4)41(70)54-28(17-74)39(68)51-25(13-33(62)63)38(67)53-27(16-57)43(72)73/h14,18-20,22-29,34,57,74H,5-13,15-17,44H2,1-4H3,(H2,45,58)(H,46,48)(H,47,65)(H,49,59)(H,50,64)(H,51,68)(H,52,66)(H,53,67)(H,54,70)(H,55,69)(H,60,61)(H,62,63)(H,72,73)/t22-,23-,24-,25-,26-,27-,28-,29-,34-/m0/s1
InChI Key
GFHXQXTURUFUAG-YEEOUUIGSA-N
Canonical SMILES
CC(C)CC(C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(C(C)C)C(=O)NC(CS)C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)O)NC(=O)C(CC(=O)N)N
Online Inquiry
Verification code
Inquiry Basket